Export financials
Kimberly-Clark Corporation (KMB)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

Kimberly-Clark Corporation Financial Statements 2025-2006 | KMB
Annual Financial Statements Kimberly-Clark Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
36.1 B | 45.2 B | 40.5 B | 43.5 B | 43.1 B | 41.6 B | 49.7 B | 37.6 B | 41.9 B | 43.3 B | 46.8 B | 40.5 B | 39.9 B | 32.9 B | 27.3 B | 24.2 B | 21.3 B | 25.3 B | - | - |
Shares |
332 M | 336 M | 338 M | 337 M | 337 M | 341 M | 343 M | 348 M | 354 M | 359 M | 364 M | 375 M | 384 M | 389 M | 399 M | 412 M | 416 M | 418 M | - | - |
Historical Prices |
109 | 135 | 120 | 129 | 128 | 122 | 121 | 104 | 95.6 | 111 | 106 | 86.3 | 80.7 | 66.7 | 49.6 | 58.6 | 51.3 | 60.4 | 68.7 | 58.6 |
Net Income |
499 M | 447 M | 1.76 B | 1.93 B | 1.81 B | 2.35 B | 2.16 B | 1.41 B | 2.28 B | 2.17 B | 1.01 B | 1.53 B | 2.14 B | 1.75 B | 1.59 B | 1.84 B | 1.88 B | 1.69 B | 1.82 B | - |
Revenue |
4.08 B | 4.1 B | 17.1 B | 17 B | 19.4 B | 19.1 B | 18.4 B | 18.5 B | 18.3 B | 18.2 B | 18.6 B | 19.7 B | 21.2 B | 21.1 B | 20.8 B | - | - | - | - | - |
Cost of Revenue |
10.5 B | 10.5 B | 10.9 B | 11.4 B | 13.5 B | 12.3 B | 12.4 B | 12.9 B | 11.8 B | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
1.46 B | 1.44 B | 6.27 B | 5.52 B | 5.99 B | 6.82 B | 6.04 B | 5.6 B | 6.55 B | 6.65 B | 6.62 B | 6.68 B | 7.24 B | 6.75 B | 6.15 B | 6.55 B | 6.42 B | 5.86 B | 5.7 B | - |
Operating Income |
2.35 B | 2.7 B | 1.93 B | 2.31 B | 2.56 B | 3.24 B | 2.99 B | 2.23 B | 3.36 B | 3.38 B | 1.61 B | 2.52 B | 2.9 B | 2.38 B | 2.44 B | 2.77 B | 2.82 B | 2.55 B | 2.62 B | - |
Interest Expense |
256 M | 270 M | 293 M | 282 M | 256 M | 252 M | 261 M | 263 M | 318 M | 319 M | 295 M | 284 M | 282 M | 285 M | 277 M | 243 M | 275 M | 304 M | 265 M | - |
EBITDA |
3.16 B | 3.48 B | 2.68 B | 3.06 B | 3.33 B | 4.04 B | 3.91 B | 3.11 B | 4.02 B | 4.02 B | 2.36 B | 3.38 B | 4.07 B | 3.54 B | 3.53 B | 3.59 B | 3.61 B | 3.32 B | 3.42 B | - |
Operating Expenses |
-886 M | -1.26 B | 4.34 B | 3.22 B | 3.43 B | 3.58 B | 3.04 B | 3.37 B | 3.25 B | 3.33 B | 5.01 B | 4.16 B | 4.03 B | 4.06 B | 3.71 B | 3.78 B | 3.6 B | 3.31 B | 3.09 B | - |
General and Administrative Expenses |
- | - | - | - | - | - | 3.25 B | 3.37 B | 3.23 B | 3.33 B | 3.44 B | 3.71 B | 4.03 B | 4.07 B | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Kimberly-Clark Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q4 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
333 M | 332 M | 332 M | - | 332 M | 332 M | 332 M | -1 M | 336 M | 337 M | 337 M | -100 K | 338 M | 338 M | 338 M | 100 M | 338 M | 337 M | 337 M | -100 K | 337 M | 337 M | 338 M | -400 K | 341 M | 341 M | 341 M | -500 K | 344 M | 344 M | 344 M | -800 K | 347 M | 349 M | 350 M | -800 K | 353 M | 354 M | 356 M | -600 K | 359 M | 360 M | 361 M | -700 K | 364 M | 364 M | 365 M | -1.5 M | 373 M | 376 M | 379 M | -900 K | 383 M | 385 M | 387 M | -800 K | 394 M | 394 M | 394 M | -400 K | 392 M | 393 M | 403 M | -1.3 M | 410 M | 414 M | 418 M | 400 M | 416 M | 416 M |
Net Income |
1.8 B | 350 M | 675 M | 499 M | 454 M | 512 M | 573 M | 447 M | 915 M | 553 M | 658 M | 512 M | 591 M | 86 M | 575 M | 515 M | 470 M | 441 M | 535 M | 361 M | 479 M | 410 M | 594 M | 546 M | 483 M | 692 M | 675 M | 556 M | 680 M | 495 M | 466 M | 421 M | 462 M | 465 M | 97 M | 625 M | 579 M | 540 M | 575 M | 518 M | 563 M | 578 M | 560 M | 344 M | 529 M | -293 M | 486 M | -63 M | 582 M | 530 M | 546 M | 558 M | 565 M | 547 M | 551 M | 286 M | 537 M | 518 M | 487 M | 401 M | 458 M | 432 M | 372 M | 492 M | 489 M | 523 M | 411 M | 492 M | 611 M | 430 M |
Revenue |
4.13 B | 4.19 B | 4.16 B | 4.08 B | 4.15 B | 4.16 B | 4.05 B | 4.1 B | 4.14 B | 4.23 B | 4.33 B | 1.68 B | 5.13 B | 5.13 B | 5.2 B | 4.96 B | 5.05 B | 5.06 B | 5.1 B | 4.96 B | 5.01 B | 4.72 B | 4.74 B | 4.84 B | 4.68 B | 4.61 B | 5.01 B | 4.58 B | 4.64 B | 4.59 B | 4.63 B | 4.57 B | 4.58 B | 4.6 B | 4.73 B | - | 4.66 B | 4.58 B | 4.5 B | - | 4.59 B | 4.59 B | 4.48 B | - | 4.72 B | 4.64 B | 4.69 B | - | 5.06 B | 4.95 B | 4.89 B | - | 5.26 B | 5.27 B | 5.32 B | - | 5.25 B | 5.27 B | 5.24 B | 5.18 B | 5.38 B | 5.26 B | 5.03 B | - | - | - | - | - | - | - |
Cost of Revenue |
2.69 B | 2.59 B | 2.63 B | 2.62 B | 2.66 B | 2.71 B | 2.54 B | 2.66 B | 2.58 B | 2.64 B | 3.24 B | 711 M | 3.29 B | 3.4 B | 3.47 B | 3.34 B | 3.51 B | 3.53 B | 3.58 B | 3.53 B | 3.53 B | 3.24 B | 3.15 B | 3.17 B | 3.09 B | 2.84 B | 3.22 B | 3.02 B | 3.08 B | 3.11 B | 3.2 B | 3.17 B | 3.17 B | 3.15 B | 3.41 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
1.44 B | 1.6 B | 1.53 B | 1.46 B | 1.49 B | 1.46 B | 1.51 B | 1.44 B | 1.56 B | 1.59 B | 1.69 B | 974 M | 1.84 B | 1.73 B | 1.73 B | 1.63 B | 1.54 B | 1.53 B | 1.52 B | 1.44 B | 1.48 B | 1.48 B | 1.59 B | 1.66 B | 1.59 B | 1.78 B | 1.79 B | 1.57 B | 1.56 B | 1.49 B | 1.43 B | 1.4 B | 1.42 B | 1.46 B | 1.32 B | 1.61 B | 1.67 B | 1.65 B | 1.66 B | 1.72 B | 1.67 B | 1.66 B | 1.64 B | 1.63 B | 1.68 B | 1.66 B | 1.66 B | 1.55 B | 1.76 B | 1.7 B | 1.66 B | 1.18 B | 1.8 B | 1.8 B | 1.82 B | 904 M | 1.77 B | 1.76 B | 1.7 B | 1.54 B | 1.59 B | 1.56 B | 1.46 B | 1.64 B | 1.61 B | 1.64 B | 1.65 B | 1.67 B | 1.73 B | 1.57 B |
Operating Income |
516 M | 633 M | 753 M | 507 M | 621 M | 592 M | 631 M | 420 M | 1.03 B | 539 M | 853 M | 254 M | 774 M | 113 M | 787 M | 712 M | 655 M | 621 M | 693 M | 521 M | 657 M | 613 M | 770 M | 749 M | 666 M | 925 M | 904 M | 751 M | 915 M | 670 M | 655 M | 639 M | 669 M | 674 M | 247 M | 828 M | 868 M | 814 M | 848 M | 905 M | 836 M | 838 M | 804 M | 630 M | 779 M | -544 M | 748 M | 158 M | 877 M | 775 M | 711 M | 517 M | 807 M | 796 M | 783 M | 140 M | 783 M | 754 M | 700 M | 611 M | 662 M | 625 M | 544 M | 699 M | 698 M | 711 M | 665 M | 717 M | 871 M | 609 M |
Interest Expense |
-13 M | -12 M | -15 M | -17 M | -16 M | -17 M | -17 M | -15 M | -15 M | -15 M | -15 M | -17 M | -20 M | -42 M | -16 M | -24 M | -18 M | -27 M | -4 M | 327 M | -10 M | -55 M | -6 M | 309 M | -40 M | -6 M | -11 M | 294 M | -11 M | -11 M | -11 M | 65 M | 64 M | 68 M | 66 M | 72 M | 78 M | 85 M | 83 M | 81 M | 81 M | 81 M | 76 M | 76 M | 74 M | 73 M | 72 M | 69 M | 72 M | 72 M | 71 M | 71 M | 73 M | 71 M | 67 M | 73 M | 70 M | 71 M | 71 M | 72 M | 70 M | 71 M | 64 M | 63 M | 59 M | 60 M | 61 M | 64 M | 67 M | 71 M |
EBITDA |
516 M | 800 M | 946 M | -107 M | 797 M | 814 M | 849 M | -137 M | 1.22 B | 727 M | 1.04 B | -301 M | 963 M | 302 M | 975 M | 159 M | 843 M | 813 M | 881 M | -42 M | 851 M | 802 M | 959 M | 145 M | 858 M | 1.13 B | 1.12 B | 54 M | 1.14 B | 906 M | 889 M | 869 M | 886 M | 898 M | 458 M | 1.01 B | 1.05 B | 994 M | 1.03 B | 1.08 B | 1.02 B | 1.02 B | 976 M | 811 M | 961 M | -355 M | 942 M | 365 M | 1.1 B | 992 M | 929 M | -85 M | 1.02 B | 1.01 B | 1 B | -473 M | 993 M | 968 M | 918 M | -186 M | 953 M | 912 M | 787 M | 905 M | 903 M | 920 M | 858 M | 937 M | 1.07 B | 976 M |
Operating Expenses |
925 M | 970 M | 781 M | 958 M | 872 M | 864 M | 878 M | 1.02 B | 538 M | 1.06 B | 833 M | 720 M | 1.06 B | 1.62 B | 939 M | 915 M | 888 M | 908 M | 827 M | 915 M | 826 M | 867 M | 819 M | 915 M | 924 M | 852 M | 887 M | 815 M | 640 M | 816 M | 773 M | 763 M | 747 M | 781 M | 1.08 B | 780 M | 799 M | 838 M | 812 M | 813 M | 834 M | 826 M | 835 M | 996 M | 903 M | 2.2 B | 911 M | 1.4 B | 888 M | 925 M | 954 M | 665 M | 998 M | 1 B | 1.04 B | 764 M | 983 M | 1 B | 1 B | 933 M | 926 M | 932 M | 919 M | 946 M | 916 M | 933 M | 982 M | 949 M | 856 M | 964 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Main types of financial statements Kimberly-Clark Corporation KMBFinancial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.
- Income Statement
Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability. - Balance Sheet
Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
Liabilities — debts and other external sources of financing.
Equity — owners' capital and retained earnings. - Cash Flow Statement
Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
- IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
- GAAP — Generally Accepted Accounting Principles used in the United States.
- RAS — Russian Accounting Standards, used domestically in Russia.
Financial reporting Kimberly-Clark Corporation plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.
In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.
Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.
Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.
Financial statements of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
USANA Health Sciences
USNA
|
$ 13.22 | -2.58 % | $ 245 M | ||
|
The Estée Lauder Companies
EL
|
$ 104.16 | -0.34 % | $ 37.7 B | ||
|
Revlon
REV
|
- | -4.41 % | $ 212 M | ||
|
e.l.f. Beauty
ELF
|
$ 113.89 | 2.41 % | $ 6.64 B | ||
|
Newell Brands
NWL
|
$ 5.67 | -0.96 % | $ 2.37 B | ||
|
Church & Dwight Co.
CHD
|
$ 111.8 | -0.6 % | $ 27.1 B | ||
|
Colgate-Palmolive Company
CL
|
$ 98.86 | -0.76 % | $ 79.9 B | ||
|
The Clorox Company
CLX
|
$ 108.41 | 1.6 % | $ 13.1 B | ||
|
Coty
COTY
|
$ 4.24 | 3.8 % | $ 3.72 B | ||
|
Edgewell Personal Care Company
EPC
|
$ 28.24 | 0.97 % | $ 1.31 B | ||
|
Hims & Hers Health
HIMS
|
$ 17.12 | -2.45 % | $ 3.85 B | ||
|
Dogness (International) Corporation
DOGZ
|
$ 0.28 | 1.42 % | $ 4.99 M | ||
|
The Procter & Gamble Company
PG
|
$ 170.22 | -0.87 % | $ 397 B | ||
|
Helen of Troy Limited
HELE
|
$ 37.02 | -0.3 % | $ 852 M | ||
|
Acme United Corporation
ACU
|
$ 66.15 | -1.21 % | $ 251 M | ||
|
LifeVantage Corporation
LFVN
|
$ 4.81 | 0.63 % | $ 60.3 M | ||
|
Mannatech, Incorporated
MTEX
|
$ 3.1 | 9.54 % | $ 5.89 M | ||
|
Inter Parfums
IPAR
|
$ 133.9 | 1.09 % | $ 4.3 B | ||
|
Nature's Sunshine Products
NATR
|
$ 10.33 | 0.1 % | $ 186 M | ||
|
Nu Skin Enterprises
NUS
|
$ 3.85 | 1.72 % | $ 190 M | ||
|
Unilever PLC
UL
|
$ 64.51 | -1.23 % | $ 141 B | ||
|
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - | |
|
Spectrum Brands Holdings
SPB
|
$ 82.13 | 1.23 % | $ 2.11 B | ||
|
United-Guardian
UG
|
$ 7.61 | 0.6 % | $ 35 M |